Skip to content
Screener

Claritev Corporation CTEV Business Segments — Total Costs & Expenses

Similar metrics at other companies

Twist Bioscience Corporation logo
TWSTReportable Segment — Total Costs & Expenses
$156.58M+16.5%
Lumen Technologies logo
LUMNReportable Segment — Total Costs & Expenses
$2.3B-25.3%
Pacira BioSciences, Inc. logo
PCRXReportable Segment — Total Costs & Expenses
$170.47M+2.1%
BlueLinx Holdings logo
BXCReportable Segment — Total Costs & Expenses
$732.61M+3.7%
Elanco Animal Health Inc. logo
ELANReportable Segment — Total Costs & Expenses
$596M+5.5%
Tarsus Pharmaceuticals, Inc. logo
TARSReportable Segment — Total Costs & Expenses
$193.82M+55.2%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Amortization of intangible assets85,90885,971171,816171,942
Loss on disposal of leases2521,6892905,006
Loss on disposal of assets5713057480
Total expenses234,069224,992472,108446,580
Operating income23,40916,57830,04826,320
Interest expense100,25399,746199,795191,382
Interest income(195)(323)(377)(811)
Transaction costs related to refinancing transaction877,879

Item 1. Financial Statements

FAQ

What is Claritev Corporation's business segments — total costs & expenses?
Claritev Corporation (CTEV) reported business segments — total costs & expenses of $234.07M in Q2 2026.
How has Claritev Corporation's business segments — total costs & expenses changed year-over-year?
Claritev Corporation's business segments — total costs & expenses increased by 4.0% year-over-year, from $224.99M to $234.07M.
What is the long-term trend for Claritev Corporation's business segments — total costs & expenses?
Over 2 years (2023 to 2025), Claritev Corporation's business segments — total costs & expenses has grown at a 8.2% compound annual growth rate (CAGR), from $799.54M to $936.65M.
What does business segments — total costs & expenses mean?
This metric aggregates all operating costs incurred by the reportable segment to generate revenue, including cost of services, general and administrative expenses, and depreciation. It provides a comprehensive view of the segment's total expenditure required to maintain its business operations. Tracking this helps assess the overall cost structure and operational efficiency of the segment.

Ask your AI about Claritev Corporation's business segments — total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude